CO2 Solution Names Thom Skinner Chief Financial Officer
Outstanding shares: 60,261,136
QUEBEC CITY, March 16 /PRNewswire-FirstCall/ – CO(2) Solution Inc. (TSX-V: CST) is pleased to announce that it has
appointed Mr. Thom Skinner, CA as Senior Vice President Finance & Chief
Financial Officer. Reporting to Glenn Kelly, President and CEO, Mr.
Skinner will be responsible for financial, accounting and information
technology operations as well as the Company’s investor relations
activities. Linda Parent, who acted as Vice President Finance and
Administration, will remain within the company with other
responsibilities and to ensure continuity of the ongoing files as well
as the transfer of financial information.
A recognized business leader and career financial executive, Mr.
Skinner’s professional experience spans more than thirty years and
includes senior financial executive roles in the financial services,
manufacturing, pharmaceutical, life sciences and biotech sectors
including extensive mergers and acquisition and capital raising work.
Mr. Skinner joins CO(2) Solution from TS Business Solutions, a Quebec-based business
consultancy which he founded in 2001 where he provided corporate
financial and administrative services to a range of public and private
companies. In this capacity, he was Chief Financial Officer of
DiagnoCure Inc., a Quebec-based biotechnology company where he managed
the company’s successful financial turnaround and secured more than $25
million in new financing on the Toronto Stock Exchange (TSX). He also
served as Interim Vice President (finance and information technology)
of Sanofi /Aventis Canada, a leading pharmaceutical company, where he
also successfully managed the integration of the 1,500 employee
Canadian portion of the Sanofi and Aventis merger. More recently, he
acted as Principal Advisor to the Chairman of Groupe Biscuits Leclerc
Inc., a major Quebec-based agri-foods company.
Prior to TS Business Solutions, Mr. Skinner held a number of senior
management positions in Canada and Europe including Executive Vice
President and Chief Financial Officer of MediSolution Ltd., Vice
President, Finance and Administration of McKesson Canada Corp., Vice
President, Finance and Administration and Chief Financial Officer of
the Business Development Bank of Canada and Vice President of Sunlife
Born in New York, NY, Mr. Skinner holds US and Canadian citizenships. He
is a member of several professional associations in Canada and has
served on several Boards of Directors including a term as Chairman of
The Montreal Children’s Hospital. He is currently a member of the Board
of Directors of the Foundation Robert-Giffard. Mr. Skinner holds a
Bachelor of Commerce degree from the University of Montreal and a
Graduate Diploma in Public Accounting from McGill University.
Commenting on the appointment, Glenn Kelly, CO(2) Solution’s President and CEO remarked, “We are delighted that Thom has
joined CO(2) Solution. His experience and track record with some of Canada’s leading
growth companies and international capital markets expertise will be
invaluable as we are rapidly expanding our operations and investor
relations efforts in line with recently announced technology scale-up
Mr. Skinner added, “I am extremely pleased and excited to be joining the
CO(2) Solution team at such an important juncture in the Company’s
development. Recently announced technology scale-up activities and
concluded collaboration agreements at CO(2) Solution have certainly set the company on a potentially exciting path
toward the advancement of their carbon capture technology and its
commercialization. The need for such a technology to address sources of
carbon pollution is urgent and the potential market is truly large. CO(2) Solution’s efficient and low cost technology is a great success story
in the making and I am looking forward to being part of its
As part of his remuneration package, Mr. Skinner was granted 450,000
options to purchase CO(2) Solution shares at a price of $0.17.
About CO(2) Solution
Based in Quebec City, CO(2) Solution is an innovator in the field of enzyme enabled carbon capture
and has been actively working to develop and commercialize the
technology for power plants and other large stationary sources of
carbon pollution. In the process, CO(2) Solution has built an extensive patent portfolio covering the use of
carbonic anhydrase for the efficient post combustion capture of carbon
dioxide with low energy aqueous solvents. Further information can be
found at www.co2solution.com.
Forward-looking Statements: Certain statements in this news release may
be forward-looking. These statements relate to future events or CO(2) Solution’s future economic performance and reflect the current
assumptions and expectations of management. Certain unknown factors may
affect the events, economic performance and results of operation
described herein. CO(2) Solution undertakes no obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under applicable
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE CO2 SOLUTION INC.